SPT 1 definition

SPT 1 means the reduction of the sum of CO2e- emissions Scope 1 and Scope 2 by at least [SPT 1 Percentage] per cent. compared to the Base Year, subject to any Recalculation, by [SPT 1 Year].
Sample 1Sample 2Sample 3
SPT 1 means that the Fossil-fuel Independent Vehicles Percentage shall be equal to or more than fifty (50) per cent. by 31 December 2025.
Sample 1Sample 2Sample 3
SPT 1 means, in relation to any day, the cumulative electricity volume of the Issuer’s SPT 1 Businesses as at that day that is sourced from renewable sources, including (without limitation) on-site renewable electricity generation and renewable electricity supply agreements or where renewable sources are not reasonably practicable, from renewable source equivalents through (without limitation) renewable energy certificates, expressed as a percentage of total electricity as at that day for the Issuer’s SPT 1 Businesses.
Sample 1Sample 2

Examples of SPT 1 in a sentence

  • If the Issuer determines that the cumulative electricity volume of the Issuer’s SPT 1 Businesses from renewable sources and/or renewable source equivalents cannot be measured, the Issuer must use reasonable estimates for the purposes of measuring SPT 1 in accordance with paragraph 3(a) above.

  • For the period from the Issue Date until the SPT 1 Test Date, the Issuer will measure, and will report no later than 90 days following the end of each calendar year, on the Issuer’s performance in respect of SPT 1 as at 31 December of the previous calendar year.

  • If SPT 1 as at the SPT 1 Test Date does not equal the SPT 1 Target, a “SPT 1 Trigger Event” occurs.

  • SPT 1 does not specify which stage of the building’s life cycle these emissions reductions come from.

  • If the Issuer cannot, for any reason, measure the cumulative electricity volume of the SPT 1 Businesses sourced from renewable sources and renewable source equivalents as at the SPT 1 Test Date, the Issuer must measure the cumulative electricity volume of SPT 1 according to the methodology which the Issuer applied on the Issue Date.

  • McComis, Ed.D.Executive Director c: Idalia ZavalaPuerto Rico Council on Higher Education izavala@ce.pr.gov Betty Coughlin Betty.coughlin@ed.govU.S. Department of Education – New York/Boston SPT 1 ATC’s mailing address is P.O. Box 55407, Station One, Bayamon, Puerto Rico, 00960.

  • Assuming this criteria is applied to all new construction projects, SPT 1 would likely align with the IEA NZE.✓ The conclusion above assumes that Atrium Ljungberg’s future growth does not contradict the assumption in the IEA NZE scenario of 75% growth in floor area between 2020 and 2050, or about 2.5% per annum, with 85% occurring in emerging markets and developing economies.

  • As defined under AEML’s GMTN Programme Historical Performance 4.2 Calibration of Sustainability Performance Targets (SPTs) SPT #1: Attain at least 60% of renewable power procurement mix by end of FY2027 FY2019 Baseline Renewable Power Mix: 3% Target Observation Date for SPT: AEML will report SPT #1 on the Target Observation Date of 30 June 2027 and no later than 30 September 2027 as of the end on the Financial Year preceding the Target Observation Date.

  • Similar to SPT 1, SPT 2 is also dependent on improvements in road transportation, the energy system, and waste management infrastructure, which may not be realized in sufficient time.

  • As such, achieving SPT 1 would more than likely mean that Atrium Ljungberg is on a pathway to satisfying point(2) above.✓ On the other hand, it is theoretically possible for Atrium Ljungberg to achieve SPT 1 by only reducing embodied emissions, with no improvements in use stage emissions.


More Definitions of SPT 1

SPT 1 means [in case of more than one SPT 1: (A)] [amount] kilogramme net CO2 emitted per ton of Cementitious Material (kg net CO2/t cem.) for the financial year [relevant year] (the "SPT 1 [in case of more than one SPT 1: (a)]") [in case of more than one SPT 1: [and] (B) [amount] kilogramme net CO2 emitted per ton of Cementitious Material (kg net CO2/t cem.) for the financial year [relevant year] (the "SPT 1(b)")].A "SPT 1 Event" occurs [in case of more than one SPT 1: (A)] if the Verification Assurance Certificate does not confirm that the amount of KPI 1 as shown in the Relevant Determination Report is equal or below the SPT 1 [in case of more than one SPT 1: (a)] (the "SPT 1 [in case of more than one SPT 1: (a)] Event") or if no Verification Assurance Certificate is available latest on the Target Reporting Date [in case of more than one SPT 1: [and] [or] (B) if the Verification Assurance Certificate does not confirm that the amount of KPI 1 as shown in the Relevant Determination Report is equal or below the SPT 1(b) (the "SPT 1(b) Event") or if no Verification Assurance Certificate is available latest on the Target Reporting Date].The SPT 1 Event shall become effective as of the date of publication of the Verification Assurance Certificate or one Business Day after the Target Reporting Date, whichever occurs earlier.][In the case of KPI 2, the following applies:
Sample 1Sample 2
SPT 1 means a reduction in the Group’s total GHG Emissions, calculated under the market- based approach, by 55 per cent. per Tonnes Sold Food from the 2020 Baseline.
Sample 1Sample 2
SPT 1 means (A) 500 kilogramme net CO2 emitted per ton of Cementitious Material (kg net CO2/t cem.) for the financial year 2026 (the "SPT 1 (a)") and (B) 400 kilogramme net CO2 emitted per ton of Cementitious Material (kg net CO2/t cem.) for the financial year 2030 (the "SPT 1 (b)").A "SPT 1 Event" occurs (A) if the Verification Assurance Certificate does not confirm that the amount of KPI 1 as shown in the Relevant Determination Report is equal or below the SPT 1 (a) (the "SPT 1 (a) Event") or if no Verification Assurance Certificate is available latest on the Target Reporting Date relevant for SPT 1 (a) and / or (B) if the Verification Assurance Certificate does not confirm that the amount of KPI 1 as shown in the Relevant Determination Report is equal or below the SPT 1 (b) (the "SPT 1 (b) Event") or if no Verification Assurance Certificate is available latest on the Target Reporting Date relevant for SPT 1 (b).The SPT 1 Event shall become effective as of the date of publication of the Verification Assurance Certificate or one Business Day after the relevant Target Reporting Date, whichever occurs earlier.STATUS, NEGATIVE PLEDGE AND GUARANTEE
Sample 1
SPT 1 means ensuring that the Recycled Plastic Percentage is at least fifty-five (55) per cent. by 31 December 2026.
Sample 1
SPT 1 means, with respect to any calendar year, the SPT 1 for such calendar year as set forth in the Sustainability Table; provided that, each year’s SPT 1 is cumulative, aggregating submissions made from January 1, 2022 through and including the end of such calendar year.
Sample 1
SPT 1 means the year-on-year increase in Net Fee Income of the Group generated from Non- Oil & Gas Projects.
Sample 1

Related to SPT 1

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Epinephrine auto-injector means a device for immediate self-administration or administration by another trained person of a measured dose of epinephrine to a person at risk of anaphylaxis.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • thalassemia means a group of inherited disorders characterised by reduced or absent amounts of haemoglobin.

  • MGD means million gallons per day. "mg/l" means milligrams per liter. "ug/l" means micrograms per liter. "ng/l" means nanograms per liter. "S.U." means standard pH unit. "kg/day" means kilograms per day.

  • HEPA filter means a high efficiency particulate absolute air filter capable of trapping and retaining 99.97 percent of fibers greater than 0.3 micrometers in mass median aerodynamic diameter equivalent.

  • Domestic content procurement preference ’ means all iron and steel used in the project are produced in the United States; the manufactured products used in the project are produced in the United States; or the construction materials used in the project are produced in the United States.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • €STRi-pTBD means, in respect of any TARGET Business Day falling in the relevant Interest Accrual Period, the €STR for the TARGET Business Day falling “p” TARGET Business Days prior to the relevant TARGET Business Day “i”;

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Principal Regulator means the body or person appointed as the Principal Regulator under the Charities Act 2011;

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Cannabis testing facility means an entity registered by

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.